Ademusire Babatunde Isaac, Wieczorek Karolina, Alonge Aishat Temitope, Rajen Anuska, Egbe Joanne, Adebambo Deborah, Offorbuike Chiamaka Bianca, Trojan Filip, Przypaśniak Zofia, Oduguwa Ifeoluwa Oluwasegun, Omitoyin Oluwaferanmi, Balogun Toluwalogo Grace
Background: Lassa fever is an acute viral haemorrhagic disease caused by the Lassa virus (LASV). It is endemic in West Africa and infects about 300,000 people each year, leading to approximately 5000 deaths annually. The development of the LASV vaccine has been listed as a priority by the World Health Organization since 2018. Considering the accelerated development and availability of vaccines against COVID-19, we set out to assess the prospects of LASV vaccines and the progress made so far...
2022: African Journal of Infectious Diseases